Open AccessS0236 Exploring the Link Between Bevacizumab and Gastrointestinal Perforations Using the FDA Adverse Event Reporting System Database
Author(s) -
Thomas A. Wichelmann,
Sufyan AbdulMujeeb,
Eli D. Ehrenpreis
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000702992.19834.54
Subject(s) - bevacizumab , medicine , perforation , gastrointestinal perforation , colorectal cancer , adverse effect , retrospective cohort study , adverse event reporting system , inclusion and exclusion criteria , complication , surgery , database , cancer , gastroenterology , chemotherapy , pathology , peritonitis , materials science , alternative medicine , computer science , punching , metallurgy